AOD 9604 peptide capsules are an oral form of the GH fragment studied for fat loss. Learn how they work, dosing, safety, and what research says.
AOD 9604 peptide capsules are an oral form of a synthetic fragment of human growth hormone (hGH 176-191) that is sold for fat loss and metabolic support. They are not FDA-approved for human use, and oral peptide absorption is poor, so their real-world effects are uncertain. Most human data on AOD 9604 comes from injected versions, not capsules.
What Is AOD 9604?
AOD 9604 is a 16-amino-acid peptide that mimics the fat-metabolizing part of human growth hormone. Researchers designed it to separate hGH's fat-burning effects from its effects on blood sugar and tissue growth.
Early laboratory and animal studies showed that AOD 9604 could increase fat breakdown and reduce body fat in obese mice. Human trials in the 2000s produced mixed results, and development as an obesity drug was discontinued.
AOD 9604 is often called a GH fragment peptide. It is not a hormone replacement, and it does not appear to raise IGF-1 levels the way full growth hormone does.
How AOD 9604 Peptide Capsules Are Supposed to Work
Oral capsules are marketed as a convenient alternative to injections. The idea is that a capsule protects the peptide through the stomach so it can be absorbed in the intestines.
In practice, peptides are fragile. Digestive enzymes and stomach acid can break them down before they reach the bloodstream. Some manufacturers use enteric coatings or liposomal delivery to improve survival, but no published human study confirms that these methods work for AOD 9604.
Injected AOD 9604 has a short half-life of roughly 20 to 30 minutes. If an oral capsule delivers only a small fraction of the peptide, the window for activity would be brief.
AOD 9604 Peptide Dose and Timing
There is no standard aod 9604 peptide dose for humans, especially in capsule form. Research on injected AOD 9604 typically uses 300 mcg per day, but that number does not translate directly to oral products.
Capsule labels often list 250 mcg to 600 mcg per capsule. Some vendors suggest one capsule daily; others recommend two. Because oral bioavailability is unknown, these doses are not evidence-based.
For timing, most guides suggest taking the capsule on an empty stomach. If you are researching when to take aod 9604 peptide, the common recommendation is 30 minutes before breakfast or before exercise. Food may slow absorption or increase peptide breakdown.
Comparing Forms and Related Peptides
| Feature | AOD 9604 Injectable | AOD 9604 Capsules | Mots-c |
|---|---|---|---|
| Delivery | Subcutaneous injection | Oral capsule | Subcutaneous injection (research) |
| Research dose | About 300 mcg per day | 250–600 mcg per capsule; no standard dose | Varies; often studied in animals at 0.5–1 mg/kg |
| Absorption | High | Low and unpredictable | High when injected |
| Main research interest | Fat loss and obesity | Fat loss (claimed) | Metabolic regulation and exercise capacity |
| FDA status | Not approved for human use | Not approved for human use | Not approved for human use |
The table shows why aod 9604 vs mots-c comparisons matter: they are different peptides with different mechanisms and research histories.
What Research Says About Fat Loss and Cartilage
Most human studies on AOD 9604 focused on weight loss. A Phase II trial in obese adults showed some reduction in body fat, but the results were not strong enough to win regulatory approval. A later study found no significant benefit over placebo.
Separate animal research explored aod 9604 peptide cartilage effects. When injected directly into joints, AOD 9604 appeared to stimulate cartilage repair in some models. There is no evidence that oral capsules deliver enough peptide to joint tissue to produce the same effect.
No large, high-quality human trial has tested AOD 9604 capsules for fat loss or joint health.
AOD 9604 vs Mots-c: How They Differ
Mots-c is a mitochondrial-derived peptide that affects how cells use energy. AOD 9604 is a growth hormone fragment that targets fat metabolism. Their pathways do not overlap much.
People interested in metabolic support sometimes compare the two. AOD 9604 is studied mainly for fat reduction, while Mots-c is studied for insulin sensitivity, exercise performance, and overall metabolic health.
Neither peptide is approved by the FDA for human use, and neither has solid oral capsule data.
Safety, Side Effects, and Legal Status
AOD 9604 is not FDA-approved for human use in the United States. Products sold as "research chemicals" or "for research use only" are not legally intended for human consumption.
In human trials of injected AOD 9604, reported side effects included headache, nausea, and reactions at the injection site. Oral capsules may cause stomach upset, but formal safety data are limited.
Long-term safety data on AOD 9604 are lacking. Anyone with a medical condition, who is pregnant, or who takes prescription medication should consult a healthcare professional before using any peptide product.
Buying AOD 9604 Peptide Capsules: What to Check
If you decide to buy aod-9604 peptide, quality control is the biggest concern. The FDA does not regulate these products, and independent testing has found that many peptide capsules contain less or more than the label states.
Look for a certificate of analysis (COA) from an independent lab. The COA should show high-performance liquid chromatography (HPLC) purity and mass spectrometry confirmation. A COA from the vendor's own lab is less reliable.
Online reviews of AOD 9604 capsules are mostly anecdotal. Some may be genuine, but others are paid or left by sellers. Treat dramatic before-and-after claims with skepticism.
Frequently Asked Questions
Is AOD 9604 available in pill form?
Yes, some vendors sell AOD 9604 peptide capsules as research chemicals, but these products are not FDA-approved for human use. Oral absorption of peptides is poor, and no human trials confirm that capsules work like injections. Buying them does not guarantee you are getting a safe or effective product.
What is the recommended AOD 9604 dose for capsules?
There is no established oral dose for AOD 9604 in humans. Injectable research often uses 300 mcg per day, while capsule labels vary widely, often listing 250–600 mcg. Because absorption is unpredictable, any oral dose is experimental, and you should talk to a healthcare professional before using one.
Does AOD 9604 really burn fat?
Injectable AOD 9604 showed modest and inconsistent fat loss in human trials, and development as an obesity drug was discontinued. There is no strong evidence that AOD 9604 capsules produce meaningful fat loss. AOD 9604 is not a proven weight-loss treatment.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.